Home > Drugs A-Z > Senna Plus

Senna Plus (NCS HealthCare of KY, Inc dba Vangard Labs)

Available Formats

Dosage Form Package Information Links
TABLET 30 TABLET in 1 BLISTER PACK (0615-5533-39) Label Information
TABLET 31 TABLET in 1 BLISTER PACK (0615-5533-31) Label Information

Complete Senna Plus Information

  • Active ingredient (in each tablet)

    Sennosides from Senna Concentrate 8.6 mg

    Sodium Dioctylsulfosuccinate 50 mg


  • Purpose

    Laxetive

    Stool Softener


  • Uses

    relieves occasional constipation (irregularity)

    generally produces a bowel movement in 6 - 12 hours


  • Warnings

    Do not use

    laxative products for longer than 1 week unless directed by a doctor

    if you are now taking mineral oil, unless directed by a doctor

    Ask a doctor before use if you have

    stomache pain, nausea, vomiting, noticed a sudden change in bowel habits that continues over a period of 2 weeks

    Stop use and ask a doctor if

    you have rectal bleeding or fail to have a bowel movement after use of a laxative.

    These may indicate a serious condition.

    If pregnant or breast-feeding,

    ask a health care professional before use. 

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away. 


  • Directions

    Take preferably at bedtime or as directed by a doctor            

    age starting dosage maximum dosage
    adults and children over 12 years 2 tablets once a day 4 tablets twice a day
    children 6 to under 12 years 1 tablet once a day 2 tablets twice a day
    children under 6 years ask a doctor  

  • Other Information

    Store at room temperature, USP


  • Other ingredients

    Croscarmellose Sodium, Dicalcium Phosphate, FD&C Yellow #5 Lake**, FD&C Yellow #6 Lake, Hypromellose, Magnesium Silicate, Magnesium Stearate, Microcrystalline Cellulose, Mineral Oil, Polyethylene Glycol, Sodium Benzoate, Sodium Lauryl Sulfate, Starch, Stearic Acid, Titanium Dioxide and Triacetin.


  • Questions

    Serious Adverse Effects Call: (800) 616-2471

    **WARNING: Contains FD&C Yellow #5 Lake (Tartrazine) as a color additive.

    *This product is not manufactured or distributed by Purdue Pharma L.P. owner of the registered trademark Senokto-S®.

    Distributed by: Major Pharmaceuticals  31778 Enterprise Drive, Livonia, MI 48150, USA

    Rev. 04/11 M-29


  • Principal Display Panel

    Senna Plus Tablets

    (Standardized senna concentrate equiv. to

    8.6mg sennosides and sodium dioctylsulfosuccinate 50mg)

    Principal Display Panel-Senna Plus Tablets (standardized senna concentrate equiv. to 8.6mg sennosides and sodium dioctylsulfosuccinat 50mg)


  • INGREDIENTS AND APPEARANCE
    SENNA PLUS 
    sennosides and docusate sodium tablet
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:0615-5533(NDC:0904-5512)
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM 50 mg
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES 8.6 mg
    Inactive Ingredients
    Ingredient Name Strength
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: L11K75P92J)  
    FD&C YELLOW NO. 5 (UNII: I753WB2F1M)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    MAGNESIUM SILICATE (UNII: 9B9691B2N9)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    MINERAL OIL (UNII: T5L8T28FGP)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    STARCH, TAPIOCA (UNII: 24SC3U704I)  
    POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    TARTARIC ACID (UNII: W4888I119H)  
    TRIACETIN (UNII: XHX3C3X673)  
    Product Characteristics
    Color ORANGE Score no score
    Shape ROUND (bi-convex) Size 10mm
    Flavor Imprint Code CPC;490
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:0615-5533-31 31 in 1 BLISTER PACK
    2 NDC:0615-5533-39 30 in 1 BLISTER PACK
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH NOT FINAL part334 06/16/2011
    Labeler - NCS HealthCare of KY, Inc dba Vangard Labs (050052943)
    Establishment
    Name Address ID/FEI Business Operations
    NCS HealthCare of KY, Inc dba Vangard Labs 050052943 RELABEL(0615-5533) , REPACK(0615-5533)